Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04088188
Title Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Academic and Community Cancer Research United
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic in Arizona Scottsdale Arizona 85259 United States Details
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 United States Details
Mayo Clinic in Rochester Rochester Minnesota 55905 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
Spartanburg Regional Medical Center Forest City North Carolina 28043 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
Aurora Cancer Care-Milwaukee West Wauwatosa Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field